Results 141 to 150 of about 1,483,959 (183)
Some of the next articles are maybe not open access.

Mutational Profiling of JAK2V617F vs. CALR mutated Primary Myelofibrosis

Clinical Lymphoma Myeloma and Leukemia, 2015
Background: The median survival of patients with primary myelofibrosis (PMF) is 5 to 7 years after diagnosis. In the majority of patients with PMF somatic mutations were detected either in Janus Kinase 2 (JAK2; in 60% of patients), Calreticulin (CALR; in 25% of patients) or MPL (in 5% of patients) genes.
Fabio Santos   +13 more
openaire   +1 more source

The JAK2V617F mutation in normal individuals takes place in differentiating cells.

Blood Cells, Molecules, and Diseases, 2017
The JAK2V617F mutation that results in a hyper-activation of the JAK2 kinase in the erythropoietin pathway is a molecular marker for myeloproliferative neoplasms. Using allele-specific Real-Time PCR, we detected the mutation in the blood of 17.3% (17/98) of normal donors; the mutant allele burden was, however, very low (1% in polycythemia vera). It was
S. Krichevsky   +4 more
semanticscholar   +3 more sources

The JAK2V617F Mutation in Blood Donors with High Haematocrit.

Blood, 2007
Abstract By the introduction for routine tests of automated counters it has become easy and extremely common the finding of abnormal or near normal laboratory results. During blood donations haematocrit (Htc) and haemoglobin level (Hb) are regularly tested to avoid a blood donation in the case of anaemia as this is the most frequent ...
Giuseppe Tagariello   +9 more
openaire   +1 more source

JAK2V617F Mutation in Patients With Thrombosis: To Screen or Not to Screen?

International Journal of Laboratory Hematology, 2011
Thrombotic complications are a main concern in patients with myeloproliferative neoplasms. Recently, a gain-of-function mutation of the gene encoding the JAK2 tyrosine kinase that results in a valine-to-phenylalanine substitution at position 617 (V617F) has been described.
Suely M Rezende, N Spector
exaly   +2 more sources

Neonatal Polycythemia May be Free of JAK2V617F Mutation

Turkiye Klinikleri Journal of Medical Sciences, 2013
Objective: Polycythemia is known as increased erythrocytosis and is linked to the erythropoiesis cascade including erythropoietin, erythropoietin receptor and intracellular signaling proteins. The Janus kinase 2 (JAK2) is the key signal transducer in the erythropoiesis cascade.
İbrahim AKALIN   +2 more
openaire   +1 more source

JAK2V617F Mutation Status and Thrombosis in Essential Thrombocythemia

Blood, 2008
Abstract Thrombosis frequently complicates the essential thrombocythemia (ET) and hypercytosis may play a role in the its occurrence as well as the platelet and coagulant activation. Therefore, we evaluated myeloproliferative and platelet and coagulant activation markers such as platelets (plts), white blood cell (WBC), haemoglobin (Hb ...
Rossella R Cacciola   +4 more
openaire   +1 more source

Polycythemia vera is not initiated by JAK2V617F mutation.

Experimental hematology, 2007
The somatic JAK2(V617F) mutation is seen in most polycythemia vera (PV) patients; however, it is not clear if JAK2(V617F) is the PV-initiating mutation.In order to examine this issue, we developed a novel real-time quantitative allele-specific PCR, in which allelic discrimination is enhanced by the synergistic effect of a mismatch in the -1 position ...
Roberto H, Nussenzveig   +7 more
openaire   +1 more source

[JAK2V617F mutation in patients with idiopathic myelofibrosis].

Zhongguo shi yan xue ye xue za zhi, 2007
To investigate JAK2V617F mutation and its clinical significance in patients with idiopathic myelofibrosis (IMF), genomic DNA was extracted from peripheral blood cell samples of 12 IMF cases. Allele-specific PCR (AS-PCR) was performed to identify JAK2V617F mutation, and the results were confirmed by sequence analysis. A retrospective study was performed
Wei-Da, Li   +5 more
openaire   +1 more source

JAK2V617Fmutation is associated with special alleles in essential thrombocythemia

Leukemia & Lymphoma, 2011
Janus kinase 2 mutation (JAK2V617F) has been identified in myeloproliferative neoplasms. Furthermore, special single nucleoside polymorphisms (SNPs) have been found to be associated with the JAK2V617F mutation. Therefore, the associations among JAK2V617F and special SNPs and the allelic location between them were investigated in patients with essential
Hui-Hua, Hsiao   +5 more
openaire   +2 more sources

Detection of the JAK2V617F mutation by asymmetric PCR and melt curve analysis

Cancer Biomarkers, 2007
The chronic myeloproliferative disorders (CMPDs) are a heterogeneous group of clonal hematopoietic diseases characterized by production of increased numbers of mature leukocytes, erythrocytes, and/or platelets. Clinically these disorders are often insidious in onset, produce nonspecific thrombotic or hemorrhagic complications, and can be easily ...
Bobbie Collett, Sutton   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy